Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-23-019611)

Filing Details

Accession Number:: 0000899243-23-019611
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-28 17:30:09
Reporting Period:: 2023-09-26

Accepted Time:: 2023-09-28 17:30:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001233	Sangamo Therapeutics Inc	SGMO	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
875045	Biogen Inc.	225 Binney St. Cambridge MA 02142		No	No	Yes	No
1810387	Biogen Ma Inc.	225 Binney St. Cambridge MA 02142		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-09-26	6,000,000	$0.50	17,652,466	No	4	S	Indirect	By Biogen MA Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Biogen MA Inc.

Footnotes

Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.